MMP-9 inhibitors promote the normalization of hematopoietic function, thus reducing the production of MDSCs in tumor-bearing BALB-neuT mice expressing an activated rat c-erbB-2/neu transgene model (93). Here, ERBB2 is linked to neoplasm.